COMBINATION FORMULATION CONTAINING SUSTAINED RELEASE METFORMIN AND IMMEDIATE RELEASE HMG-COA REDUCTASE INHIBITOR
ABSTRACT THE PRESENT INVENTION RELATES TO A COMBINATION FORMULATION CONTAINING METFORMIN FOR TREATING NON-INSULIN-DEPENDENT DIABETES AND AN HMG-COA REDUCTASE INHIBITOR FOR TREATING DYSLIPIDEMIA. THE PRESENT INVENTION PROVIDES A COMBINATION FORMULATION AND A METHOD FOR PREPARING THE COMBINATION FORMU...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | ABSTRACT THE PRESENT INVENTION RELATES TO A COMBINATION FORMULATION CONTAINING METFORMIN FOR TREATING NON-INSULIN-DEPENDENT DIABETES AND AN HMG-COA REDUCTASE INHIBITOR FOR TREATING DYSLIPIDEMIA. THE PRESENT INVENTION PROVIDES A COMBINATION FORMULATION AND A METHOD FOR PREPARING THE COMBINATION FORMULATION, WHEREIN THE COMBINATION FORMULATION CONTAINS METFORMIN AND AN HMG-COA REDUCTASE INHIBITOR, AND HAS EFFECTIVELY IMPROVED STABILITY BY BLOCKING PHYSICAL AND CHEMICAL REACTIONS BETWEEN THE ACTIVE INGREDIENTS WHILE SECURING THE STABLE RELEASE OF RESPECTIVE ACTIVE INGREDIENTS. (FIG. 1) |
---|